We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos).
- Authors
Targownik, Laura E; Leslie, William D; Davison, K Shawn; Goltzman, David; Jamal, Sophie A; Kreiger, Nancy; Josse, Robert G; Kaiser, Stephanie M; Kovacs, Christopher S; Prior, Jerilynn C; Zhou, Wei; CaMos Research Group
- Abstract
Proton pump inhibitor (PPI) use has been identified as a risk factor for hip and vertebral fractures. Evidence supporting a relationship between PPI use and osteoporosis remains scant. Demonstrating that PPIs are associated with accelerated bone mineral density (BMD) loss would provide supportive evidence for a mechanism through which PPIs could increase fracture risk.
- Publication
The American journal of gastroenterology, 2012, Vol 107, Issue 9, p1361
- ISSN
1572-0241
- Publication type
Journal Article
- DOI
10.1038/ajg.2012.200